EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Increase in Imported Plasmodium vivax Malaria in New York City: Clinical and Demographic Trends Following Recent Migration

Cesar G Berto iD, Maria Alyssa Policarpio iD, Coral Vargas-Pena, Mike Antwi iD, Sally Slavinski, Asha Abdool iD, Renee N King, Tsoline Kojaoghlanian iD, Johanna P Daily, Nishant Prasad iD, Maria R Velasquez iD, Alison D Ridpath iD und 1 weitere

Open Forum Infectious Diseases · 02.06.2026 · 13 (6)

DOI: 10.1093/ofid/ofag293 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 16.05.2026. Verfasst von Cesar G Berto und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Plasmodium vivax causes over 9 million malaria cases globally. While rare in the United States, New York City (NYC) reports the highest number of travel-associated cases. In 2023, cases peaked alongside the arrival of >265 000 migrants from malaria-endemic regions.

Methods

We retrospectively reviewed P. vivax cases reported to the NYC Department of Health (2018–2024) and analyzed clinical data from patients admitted to NYC Health + Hospitals (H + H) over the same period. Cases were confirmed via blood smear, rapid diagnostic test, or polymerase chain reaction (PCR). Data on travel history, presentation, diagnostics, treatment, and outcomes were analyzed.

Results

In NYC, the number of P. vivax cases rose from 6 of 206 malaria cases (2.9%) in 2018 to a record 63 of 346 (18.2%) in 2023, with 43 of 250 (17.2%) in 2024. Of 41 H + H admissions, 40 (97.6%) were recent migrants, mainly from South America and Asia. Severe malaria occurred in 10 patients (24.4%), with 5 (12.2%) requiring intensive care. Rapid diagnostic tests were used in 38 cases (93%); PCR had a median 8-day turnaround. Primaquine was prescribed to 32 (78%) after G6PD testing. Relapses occurred in 7 patients (17%), mostly among those not receiving liver-stage therapy.

Conclusions

The rise in P. vivax malaria in NYC parallels migration trends from endemic areas. Timely diagnosis and liver-stage therapy are critical to reducing morbidity and relapses. While nearly all cases were imported, delayed species confirmation or incomplete treatment risks potential local transmission, requiring heightened clinician awareness and public health vigilance.

Schlagwörter

Stichwörter der Autor:innen

P. vivaximported malariatravel

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Department of Medicine, NewYork City Health + Hospitals/Jacobi, Albert Einstein College of Medicine, Bronx, New York, USA.
  • The Bureau of Communicable Disease, NewYork City Department of Health & Mental Hygiene, New York, New York, USA.
  • Division of Pediatric Infectious Diseases, Maimonides Children's Hospital of Brooklyn, Brooklyn, New York, USA.
  • Division of Infectious Diseases, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NewYork, USA.
  • Division of Infectious Diseases, NewYork-Presbyterian Queens Hospital, Flushing, New York, USA.

ORCID-Profile: Cesar G Berto, Maria Alyssa Policarpio, Mike Antwi, Asha Abdool, Tsoline Kojaoghlanian, Nishant Prasad, Maria R Velasquez, Alison D Ridpath, Christina M Coyle

Förderung

  • United States Centers for Disease Control and Prevention

Zitieren

APA

Berto, C. G., Policarpio, M. A., Vargas-Pena, C., Antwi, M., Slavinski, S., Abdool, A., King, R. N., Kojaoghlanian, T., Daily, J. P., Prasad, N., Velasquez, M. R., Ridpath, A. D., & Coyle, C. M. (2026). An Increase in Imported Plasmodium vivax Malaria in New York City: Clinical and Demographic Trends Following Recent Migration. Open Forum Infectious Diseases, 13(6). https://doi.org/10.1093/ofid/ofag293

Vancouver

Berto CG, Policarpio MA, Vargas-Pena C, Antwi M, Slavinski S, Abdool A, et al. An Increase in Imported Plasmodium vivax Malaria in New York City: Clinical and Demographic Trends Following Recent Migration. Open Forum Infectious Diseases. 2026;13(6). doi:10.1093/ofid/ofag293

BibTeX
@article{Berto2026,
  author = {Berto, Cesar G and Policarpio, Maria Alyssa and Vargas-Pena, Coral and Antwi, Mike and Slavinski, Sally and Abdool, Asha and King, Renee N and Kojaoghlanian, Tsoline and Daily, Johanna P and Prasad, Nishant and Velasquez, Maria R and Ridpath, Alison D and Coyle, Christina M},
  title = {An Increase in Imported Plasmodium vivax Malaria in New York City: Clinical and Demographic Trends Following Recent Migration},
  journal = {Open Forum Infectious Diseases},
  year = {2026},
  volume = {13},
  number = {6},
  doi = {10.1093/ofid/ofag293}
}
Kostenlos starten →